Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


EMA Highlights: EMA chief ‘building leaner organisation’

Written by | 30 Aug 2016 | All Medical News

by Gary Finnegan: The European Medicines Agency (EMA) has restructured its staff in a bid to efficiently deal changing demand. The Agency faces the challenge of keeping up with growing demand without consuming additional resources.

Changes introduced on 1 September will make it “leader, more streamlined organisation”, improving its effectiveness, the Agency said.

“We want to do more with the resources we have by designing the Agency’s structures and processes around the lifespan of medicines,” said EMA’s Executive Director Guido Rasi. “With the changes announced today we are fine-tuning our operating model which has proven successful over the past two years and strengthening the efficiency of our administration.”

Among the major changes are a reduction in the number of divisions dealing with human medicines from four to three. There are now divisions responsible for supporting medicines developers, the evaluation of medicines, and oversight of medicines – including pharmacovigilance and inspections.

A new function has been created to strengthen collaboration between EMA and national authorities. The Agency, which signed a 25-year lease on new headquarters in London this year but is expected to relocate post-Brexit, also slimmed down its administrative and corporate services.

“Interactions between stakeholders and the Agency will not be affected by these changes,” the EMA said.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.